Skip to content

Clinical trials

Phase 3 Crohn Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: Netherlands Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20065
20071
20082
20102
20115
20121
20131
20141
20153
20164
20177
20189
20192
20203
20213
20221
20231
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated14
Recruiting13
Active, not recruiting5
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie9
Janssen Research & Development, LLC7
Celgene6
Takeda6
Eli Lilly and Company5
Abbott3
GlaxoSmithKline3
Shire3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease63
Inflammatory Bowel Diseases9
Colitis, Ulcerative5
Colitis3
Colonic Neoplasms1
Fistula1
Gastroenteritis1
Intestinal Diseases1
Intestinal Fistula1
Irritable Bowel Syndrome1

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.